BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19468669)

  • 1. A novel therapeutic strategy with anti-CD9 antibody in gastric cancers.
    Nakamoto T; Murayama Y; Oritani K; Boucheix C; Rubinstein E; Nishida M; Katsube F; Watabe K; Kiso S; Tsutsui S; Tamura S; Shinomura Y; Hayashi N
    J Gastroenterol; 2009; 44(9):889-96. PubMed ID: 19468669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD9-mediated activation of the p46 Shc isoform leads to apoptosis in cancer cells.
    Murayama Y; Miyagawa J; Oritani K; Yoshida H; Yamamoto K; Kishida O; Miyazaki T; Tsutsui S; Kiyohara T; Miyazaki Y; Higashiyama S; Matsuzawa Y; Shinomura Y
    J Cell Sci; 2004 Jul; 117(Pt 15):3379-88. PubMed ID: 15226408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [EGFR-blockade by antibody Cetuximab inhibits the growth of human gastric cancer xenograft in nude mice and its possible mechanism].
    Zhang J; Ji J; Yuan F; Ma T; Ye ZB; Yu YY; Liu BY; Zhu ZG
    Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):85-9. PubMed ID: 19538880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tetraspanin CD9 regulates migration, adhesion, and homing of human cord blood CD34+ hematopoietic stem and progenitor cells.
    Leung KT; Chan KY; Ng PC; Lau TK; Chiu WM; Tsang KS; Li CK; Kong CK; Li K
    Blood; 2011 Feb; 117(6):1840-50. PubMed ID: 21063023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KRC-408, a novel c-Met inhibitor, suppresses cell proliferation and angiogenesis of gastric cancer.
    Hong SW; Jung KH; Park BH; Zheng HM; Lee HS; Choi MJ; Yun JI; Kang NS; Lee J; Hong SS
    Cancer Lett; 2013 May; 332(1):74-82. PubMed ID: 23348694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 19-peptide, a fragment of tumstatin, inhibits the growth of poorly differentiated gastric carcinoma cells in vitro and in vivo.
    He Y; Jiang Y; Li YJ; Liu XH; Zhang L; Liu LJ; Shi H; Li HN; Ma YC; Jin XM
    J Gastroenterol Hepatol; 2010 May; 25(5):935-41. PubMed ID: 20546447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel CD9-targeted therapies in gastric cancer.
    Murayama Y; Oritani K; Tsutsui S
    World J Gastroenterol; 2015 Mar; 21(11):3206-13. PubMed ID: 25805926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Difference of gene expression profile in human gastric cancer grafted onto nude mice treated with WCA].
    Zhao AG; Yang JK; You SF; Li T; Zhao HL; Gu Y; Tang LD
    Zhongguo Zhong Yao Za Zhi; 2007 Oct; 32(19):2028-36. PubMed ID: 18161298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potential of amanitin-conjugated anti-epithelial cell adhesion molecule monoclonal antibody against pancreatic carcinoma.
    Moldenhauer G; Salnikov AV; Lüttgau S; Herr I; Anderl J; Faulstich H
    J Natl Cancer Inst; 2012 Apr; 104(8):622-34. PubMed ID: 22457476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor effect and mechanisms of arsenic trioxide on subcutaneously implanted human gastric cancer in nude mice.
    Wu DD; Xiao YF; Geng Y; Hou J
    Cancer Genet Cytogenet; 2010 Apr; 198(2):90-6. PubMed ID: 20362223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide.
    Takahashi N; Haba A; Matsuno F; Seon BK
    Cancer Res; 2001 Nov; 61(21):7846-54. PubMed ID: 11691802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD9 overexpression suppressed the liver metastasis and malignant ascites via inhibition of proliferation and motility of small-cell lung cancer cells in NK cell-depleted SCID mice.
    Zheng R; Yano S; Zhang H; Nakataki E; Tachibana I; Kawase I; Hayashi S; Sone S
    Oncol Res; 2005; 15(7-8):365-72. PubMed ID: 16491954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of orally bioavailable farnesyltransferase inhibitor, ABT-100, is mediated by antiproliferative, proapoptotic, and antiangiogenic effects in xenograft models.
    Ferguson D; Rodriguez LE; Palma JP; Refici M; Jarvis K; O'Connor J; Sullivan GM; Frost D; Marsh K; Bauch J; Zhang H; Lin NH; Rosenberg S; Sham HL; Joseph IB
    Clin Cancer Res; 2005 Apr; 11(8):3045-54. PubMed ID: 15837760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of advanced human prostate tumor growth in athymic mice by silibinin feeding is associated with reduced cell proliferation, increased apoptosis, and inhibition of angiogenesis.
    Singh RP; Sharma G; Dhanalakshmi S; Agarwal C; Agarwal R
    Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):933-9. PubMed ID: 14504208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fully human antibodies to MCAM/MUC18 inhibit tumor growth and metastasis of human melanoma.
    Mills L; Tellez C; Huang S; Baker C; McCarty M; Green L; Gudas JM; Feng X; Bar-Eli M
    Cancer Res; 2002 Sep; 62(17):5106-14. PubMed ID: 12208768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic anti-hepatocyte growth factor monoclonal antibody therapy induces the regression of intracranial glioma xenografts.
    Kim KJ; Wang L; Su YC; Gillespie GY; Salhotra A; Lal B; Laterra J
    Clin Cancer Res; 2006 Feb; 12(4):1292-8. PubMed ID: 16489086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tetraspanin CD9 inhibits the proliferation and tumorigenicity of human colon carcinoma cells.
    Ovalle S; Gutiérrez-López MD; Olmo N; Turnay J; Lizarbe MA; Majano P; Molina-Jiménez F; López-Cabrera M; Yáñez-Mó M; Sánchez-Madrid F; Cabañas C
    Int J Cancer; 2007 Nov; 121(10):2140-52. PubMed ID: 17582603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosine kinase inhibitor SU6668 inhibits peritoneal dissemination of gastric cancer via suppression of tumor angiogenesis.
    Tokuyama J; Kubota T; Saikawa Y; Yoshida M; Furukawa T; Otani Y; Kumai K; Kitajima M
    Anticancer Res; 2005; 25(1A):17-22. PubMed ID: 15816514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravoxel incoherent motion diffusion-weighted imaging for monitoring chemotherapeutic efficacy in gastric cancer.
    Song XL; Kang HK; Jeong GW; Ahn KY; Jeong YY; Kang YJ; Cho HJ; Moon CM
    World J Gastroenterol; 2016 Jun; 22(24):5520-31. PubMed ID: 27350730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model.
    Ding C; Li L; Yang T; Fan X; Wu G
    BMC Cancer; 2016 Oct; 16(1):791. PubMed ID: 27729020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.